Shi Z, Mabuchi T, Riutta S, Wu X, Peterson F, Volkman B
J Psoriasis Psoriatic Arthritis. 2024; 8(3):107-117.
PMID: 39296310
PMC: 11361516.
DOI: 10.1177/24755303231159106.
Jin S, Wan S, Xiong R, Li Y, Dong T, Guan C
Inflamm Res. 2024; 73(8):1311-1332.
PMID: 38839628
DOI: 10.1007/s00011-024-01900-w.
Tsiogkas S, Mavropoulos A, Dardiotis E, Zafiriou E, Bogdanos D
Front Immunol. 2024; 15:1325356.
PMID: 38835766
PMC: 11148216.
DOI: 10.3389/fimmu.2024.1325356.
Cheng Y, Acedera J, Li Y, Shieh S
Cell Death Differ. 2024; 31(8):970-982.
PMID: 38714880
PMC: 11303697.
DOI: 10.1038/s41418-024-01304-7.
Sieminska I, Pieniawska M, Grzywa T
Clin Rev Allergy Immunol. 2024; 66(2):164-191.
PMID: 38642273
PMC: 11193704.
DOI: 10.1007/s12016-024-08991-7.
N6.2 phospholipids induce immature-like dendritic cells with a migratory-regulatory-like transcriptional signature.
Cuaycal A, Teixeira L, Lorca G, Gonzalez C
Gut Microbes. 2023; 15(2):2252447.
PMID: 37675983
PMC: 10486300.
DOI: 10.1080/19490976.2023.2252447.
CCL20 is a potential therapeutic target associated with immune infiltration in breast cancer.
Zhai H, Zhang N, Mo D, Qin T
J Int Med Res. 2023; 51(8):3000605231171762.
PMID: 37571985
PMC: 10423453.
DOI: 10.1177/03000605231171762.
Inflammation-related proteomics demonstrate landscape of fracture blister fluid in patients with acute compartment syndrome.
Long Y, Li Y, Wang T, Ni A, Guo J, Dong Q
Front Immunol. 2023; 14:1161479.
PMID: 37090725
PMC: 10115951.
DOI: 10.3389/fimmu.2023.1161479.
A sharp decrease of Th17, CXCR3+-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis.
Tsiogkas S, Mavropoulos A, Dardiotis E, Zafiriou E, Bogdanos D
Clin Exp Immunol. 2022; 210(1):79-89.
PMID: 35925616
PMC: 9585551.
DOI: 10.1093/cei/uxac069.
The Protective Effect of the Soluble Egg Antigen of in A Mouse Skin Transplantation Model.
Jiang J, Li J, Zhang Y, Zhou C, Guo C, Zhou Z
Front Immunol. 2022; 13:884006.
PMID: 35911717
PMC: 9332893.
DOI: 10.3389/fimmu.2022.884006.
Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice.
Yong L, Yu Y, Li B, Ge H, Zhen Q, Mao Y
Nat Commun. 2022; 13(1):4255.
PMID: 35869084
PMC: 9307837.
DOI: 10.1038/s41467-022-31935-8.
Regulatory T Cells Require CCR6 for Skin Migration and Local Suppression of Vitiligo.
Essien K, Katz E, Strassner J, Harris J
J Invest Dermatol. 2022; 142(12):3158-3166.e7.
PMID: 35777498
PMC: 10198248.
DOI: 10.1016/j.jid.2022.05.1090.
Role of chemokine systems in cancer and inflammatory diseases.
Li H, Wu M, Zhao X
MedComm (2020). 2022; 3(2):e147.
PMID: 35702353
PMC: 9175564.
DOI: 10.1002/mco2.147.
CCL27 is a crucial regulator of immune homeostasis of the skin and mucosal tissues.
Davila M, Xu M, Huang C, Gaddes E, Winter L, Cantorna M
iScience. 2022; 25(6):104426.
PMID: 35663027
PMC: 9157018.
DOI: 10.1016/j.isci.2022.104426.
Relationship between Immune Cells, Depression, Stress, and Psoriasis: Could the Use of Natural Products Be Helpful?.
Alesci A, Lauriano E, Fumia A, Irrera N, Mastrantonio E, Vaccaro M
Molecules. 2022; 27(6).
PMID: 35335319
PMC: 8954591.
DOI: 10.3390/molecules27061953.
Immunopathology and Immunotherapy of Inflammatory Skin Diseases.
Song A, Lee S, Kim J
Immune Netw. 2022; 22(1):e7.
PMID: 35291649
PMC: 8901701.
DOI: 10.4110/in.2022.22.e7.
Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice.
Li F, Han D, Wang B, Zhang W, Zhao Y, Xu J
Mediators Inflamm. 2022; 2022:5782922.
PMID: 35069008
PMC: 8767412.
DOI: 10.1155/2022/5782922.
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches.
Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A
Biomedicines. 2021; 9(11).
PMID: 34829740
PMC: 8615182.
DOI: 10.3390/biomedicines9111511.
Skin Barrier Dysregulation in Psoriasis.
Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M
Int J Mol Sci. 2021; 22(19).
PMID: 34639182
PMC: 8509518.
DOI: 10.3390/ijms221910841.
Therapeutic Development Based on the Immunopathogenic Mechanisms of Psoriasis.
Tseng J, Chang Y, Huang C, Hsu L, Chuang T
Pharmaceutics. 2021; 13(7).
PMID: 34371756
PMC: 8308930.
DOI: 10.3390/pharmaceutics13071064.